CN103961444B - A kind of external traditional Chinese medicinal application treating lower limb injury - Google Patents
A kind of external traditional Chinese medicinal application treating lower limb injury Download PDFInfo
- Publication number
- CN103961444B CN103961444B CN201410217164.XA CN201410217164A CN103961444B CN 103961444 B CN103961444 B CN 103961444B CN 201410217164 A CN201410217164 A CN 201410217164A CN 103961444 B CN103961444 B CN 103961444B
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- lower limb
- parts
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention discloses a kind of external traditional Chinese medicinal application treating lower limb injury. Lower limb injury belongs to motherland's medical science " lower limb urticaria " category, and red with skin, swollen, hot, pain is principal character clinically, and with General Symptomies in various degree such as heatings. Many have heat because of blood system, and burning hot heresy of pathogenic wind-warm is invaded, and strongly fragrant in skin or skin, mucosa breakage is infected evil malicious and sends out. Present invention choosing has heat-clearing and toxic substances removing, promoting blood circulation and detumescence, the Chinese medicine Radix Chimonanthi praecocis of removing obstruction in the collateral to relieve pain, Herba galii veri, Herba oxalidis corymbosae, Herba Impatientis Chinensis, Radix Evodiae Leptae, Radix Clinopodii polycephali, Herba polygoni senticosi, Herba Abri, Herba Andrographis, add vaseline and be made into externally dressing, through clinical trial, total effective rate is 92.85%, matched group total effective rate is 72.41%, two groups of comparison therapy groups are substantially better than matched group, and without obvious toxic and side effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of external traditional Chinese medicinal application treating lower limb injury.
Background technology
Erysipelas is that Intradermal lymph pipe network is infected caused acute infectious diseases by beta hemolytic streptococcus. Skin is rubescent suddenly, and color, as being coated with pellet, is a kind of acute infectious diseases. Its feature is that red pain is forged in affected part, outwards expands rapidly. Primary disease is mainly in lower limb and Head And Face. Erysipelas is early recognized by the traditional Chinese medical science, the name of disease such as existing " red heat rash ", " red Piao ", all erysipelas of Shengji Zonglu in "Nei Jing" " say: " gas of pyretic toxicity breaks out between skin, must not leak, then accumulation of heat is erysipelas. With its color as being coated with the red of pellet, answer again yang-energy and lie prostrate in skin, put the pellet of meaning also ". Tang's Sun Simiao " prescriptions worth thousand gold ": " one fire caused by lightning or other natural phenomena of erysipelas has red, such as the color of pellet painting suddenly in meat ". Later age, the traditional Chinese medical science was called " erysipelas on the head " by sending out in the erysipelas of head, was called " erysipelas " by sending out in lower limb lower limb foot. Modern medicine is to its treatment based on penicillin infection, and in recent years, we add on the basis of western medical treatment and have used one group of Chinese medicine composition, and compared with individually treating with Western medicine, effect is more lasting, and curative effect is higher.
Summary of the invention
It is an object of the invention to provide a kind of external traditional Chinese medicinal application treating lower limb injury. Lower limb injury belongs to motherland's medical science " lower limb urticaria " category, and red with skin, swollen, hot, pain is principal character clinically, and with General Symptomies in various degree such as heatings. Many have heat because of blood system, and burning hot heresy of pathogenic wind-warm is invaded, and strongly fragrant in skin or skin, mucosa breakage is infected evil malicious and sends out. Chinese traditional treatment should heat-clearing and toxic substances removing, promoting blood circulation and detumescence, removing obstruction in the collateral to relieve pain.
It is an object of the invention to be achieved through the following technical solutions, the external traditional Chinese medicinal application of this treatment lower limb injury is made up of the Chinese medicine of following weight portion: Radix Chimonanthi praecocis 3-9 part, Herba galii veri 15-30 part, Herba oxalidis corymbosae 15-30 part, Herba Impatientis Chinensis 30-60 part, Radix Evodiae Leptae 15-30 part, Radix Clinopodii polycephali 9-15 part, Herba polygoni senticosi 50-60 part, Herba Abri 9-15 part, Herba Andrographis 15-30 part.
Preferred: Radix Chimonanthi praecocis 6 parts, Herba galii veri 22.5 parts, Herba oxalidis corymbosae 22.5 parts, Herba Impatientis Chinensis 45 parts, Radix Evodiae Leptae 22.5 parts, Radix Clinopodii polycephali 12 parts, Herba polygoni senticosi 55 parts, Herba Abri 12 parts, Herba Andrographis 22.5 parts.
Preparation method: various Chinese medicines of the present invention are ground into powder altogether, adds vaseline 100g, stirs evenly standby.
Fang Zhong: Radix Chimonanthi praecocis, Herba Impatientis Chinensis: heat-clearing and toxic substances removing, stasis-dispelling and pain-killing, promoting blood circulation and detumescence; Herba galii veri: heat-clearing and toxic substances removing, promoting the circulation of blood pain relieving; Herba oxalidis corymbosae: heat-clearing and toxic substances removing, eliminating stasis to stop pain; Radix Evodiae Leptae: heat-clearing and toxic substances removing, expelling wind and removing dampness, eliminating stasis to stop pain; Radix Clinopodii polycephali: heat-clearing and toxic substances removing, dampness removing are active;
Herba polygoni senticosi: heat-clearing and toxic substances removing, dissipating blood stasis for subsidence of swelling; Herba Abri: heat-clearing and toxic substances removing, dissipating blood stasis soothing liver-QI; Herba Andrographis: heat-clearing and toxic substances removing, removing heat from blood are subsided a swelling.
Clinical data
1. physical data includes the 60 standard compliant patients of example in clinical observation plan, is randomly divided into treatment group and matched group, often organizes 30 examples. In therapeutic process, treatment group comes off 2 examples, and matched group comes off 1 example, finally includes statistics patient 57 example in. Wherein, male 33 examples, female 24 example. Age 16-83 year, 43.5 years old mean age. Course of disease 1d��7d, average course of disease 3.7d. Companion's tinea pedis medical history person 33 example; Wound medical history person 12 example; Unknown cause person 15 example; First episode person 38 example, repeatedly sends out patient 22 example; Two groups of there are no significant in sex, the age course of disease and cause of disease differences (P > 0.05), have comparability.
2. diagnostic criteria (1) majority betides lower limb, is secondly Head And Face. Neonate erysipelas, is often migrans. (2) the red red scorching hot shape as being coated with pellet in local, swelling pain, have obvious boundary with normal skin, erythema may occur in which vesicle, purpura sometimes, occasionally have suppuration or cutaneous necrosis, be often accompanied by lymph node and swell and ache near pathological changes. (3) start namely there is aversion to cold, heating, headache, the symptoms such as the whole body is uncomfortable. (4) can there be the medical histories such as the breakage of skin, mucosa or tinea pedis. (5) blood leukocytes sum and neutrophilic granulocyte substantially increase.
3. inclusive criteria (1) meets the lower limb injury patient of diagnostic criteria; (2) penicillin skin test is negative.
4. reject case standard (1) person that do not meet inclusive criteria or data not umbra rings judgement person; (2) not by regulation medication, it is impossible to judge curative effect person; (3) antiphlogistine is not tolerated, anaphylaxis person occurs. (4) skin lesion has diabrosis person. (5) penicillin skin test is positive.
5. the case standard that comes off meets, through screening, the experimenter including research into group standard in, and no matter when what is because exiting, as long as the treatment cycle that the scheme that is not fully complete specifies, is all judged to the case that comes off.
6. Therapeutic Method treatment group patient's external application external traditional Chinese medicinal application of the present invention, weigh Radix Chimonanthi praecocis 6g, Herba galii veri 22.5g, Herba oxalidis corymbosae 22.5g, Herba Impatientis Chinensis 45g, Radix Evodiae Leptae 22.5g, Radix Clinopodii polycephali 12g, Herba polygoni senticosi 55g, Herba Abri 12g, Herba Andrographis 22.5g, it is ground into powder altogether, add vaseline 100g, stir evenly, take appropriate external application affected part, every day twice. Matched group: penicillin 8,000,000 unit adds 100 milliliters of intravenous drips of normal saline, every day 1 time.
6. curative effect determinate standard is formulated according to Sun Chuanxing " clinical disease diagnosis is according to curing improvement standard ". Cure: transference cure, blood routine examination total white blood cells and neutrophilic granulocyte number are normal; Taking a turn for the better: symptom is substantially alleviated, blood routine examination total white blood cells and neutrophilic granulocyte number are close to normal; Invalid: symptom is not alleviated, blood routine examination total white blood cells and neutrophilic granulocyte number have no reduction.
7. liang group comparitive study is in Table 1.
The comparison of 1 liang of table group patient's curative effect
Adopting chi-square criterion, two groups of cure rate difference of P < 0.01. have statistical significance, and treatment group is better than matched group
8. do not find toxicity during untoward reaction treatment.
Detailed description of the invention
Embodiment one: weigh Radix Chimonanthi praecocis 6g, Herba galii veri 22.5g, Herba oxalidis corymbosae 22.5g, Herba Impatientis Chinensis 45g, Radix Evodiae Leptae 22.5g, Radix Clinopodii polycephali 12g, Herba polygoni senticosi 55g, Herba Abri 12g, Herba Andrographis 22.5g, above each medicine is ground into powder altogether, add vaseline 100g, stir evenly standby.
Embodiment two: weigh Radix Chimonanthi praecocis 3g, Herba galii veri 15g, Herba oxalidis corymbosae 15g, Herba Impatientis Chinensis 30g, Radix Evodiae Leptae 15g, Radix Clinopodii polycephali 9g, Herba polygoni senticosi 60g, Herba Abri 9g, Herba Andrographis 15g, is ground into powder altogether by above each medicine, adds vaseline 100g, stirs evenly standby.
Embodiment three: weigh Radix Chimonanthi praecocis 9g, Herba galii veri 30g, Herba oxalidis corymbosae 30g, Herba Impatientis Chinensis 60g, Radix Evodiae Leptae 30g, Radix Clinopodii polycephali 15g, Herba polygoni senticosi 50g, Herba Abri 15g, Herba Andrographis 30g, above each medicine is ground into powder altogether, add vaseline 100g, stir evenly standby.
Claims (2)
1. the external traditional Chinese medicinal application treating lower limb injury, it is characterised in that this external traditional Chinese medicinal application is made up of the Chinese medicine of following weight portion: Radix Chimonanthi praecocis 3-9 part, Herba galii veri 15-30 part, Herba oxalidis corymbosae 15-30 part, Herba Impatientis Chinensis 30-60 part, Radix Evodiae Leptae 15-30 part, Radix Clinopodii polycephali 9-15 part, Herba polygoni senticosi 30-60 part, Herba Abri 9-15 part, Herba Andrographis 15-30 part.
2. a kind of external traditional Chinese medicinal application treating lower limb injury according to claim 1, it is characterised in that this external traditional Chinese medicinal application is made up of the Chinese medicine of following weight portion: Radix Chimonanthi praecocis 6 parts, Herba galii veri 22.5 parts, Herba oxalidis corymbosae 22.5 parts, Herba Impatientis Chinensis 45 parts, Radix Evodiae Leptae 22.5 parts, Radix Clinopodii polycephali 12 parts, Herba polygoni senticosi 45 parts, Herba Abri 12 parts, Herba Andrographis 22.5 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410217164.XA CN103961444B (en) | 2014-05-17 | 2014-05-17 | A kind of external traditional Chinese medicinal application treating lower limb injury |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410217164.XA CN103961444B (en) | 2014-05-17 | 2014-05-17 | A kind of external traditional Chinese medicinal application treating lower limb injury |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103961444A CN103961444A (en) | 2014-08-06 |
CN103961444B true CN103961444B (en) | 2016-06-08 |
Family
ID=51231765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410217164.XA Active CN103961444B (en) | 2014-05-17 | 2014-05-17 | A kind of external traditional Chinese medicinal application treating lower limb injury |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103961444B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800380A (en) * | 2015-03-30 | 2015-07-29 | 夏家玉 | Traditional Chinese medicine composition for treating erysipelas on lower legs and nursing method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009059158A1 (en) * | 2007-11-02 | 2009-05-07 | Hutchison Medipharma Enterprises Limited | Andrographis paniculata extract |
CN103386104A (en) * | 2013-07-01 | 2013-11-13 | 李春芝 | Traditional Chinese medicine composite for curing erysipelas and preparation method thereof |
-
2014
- 2014-05-17 CN CN201410217164.XA patent/CN103961444B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009059158A1 (en) * | 2007-11-02 | 2009-05-07 | Hutchison Medipharma Enterprises Limited | Andrographis paniculata extract |
CN103386104A (en) * | 2013-07-01 | 2013-11-13 | 李春芝 | Traditional Chinese medicine composite for curing erysipelas and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
20种中草药制剂抑菌试验初报;郁建生,杨冰,周芳英,黄雪飞,姚红燕,裴庆元;《中兽医学杂志》;19951231(第1期);第2-4页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103961444A (en) | 2014-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705906B (en) | Chinese medicine hot compress plaster for improving microcirculation and relieving pain | |
CN103961444B (en) | A kind of external traditional Chinese medicinal application treating lower limb injury | |
CN103919952A (en) | Gel preparation for treating hemorrhoids and preparation method thereof | |
CN104623607B (en) | A kind of Chinese medicine composition for treating rheumatic and rheumatoid diseases | |
CN106963921A (en) | It is a kind of to treat external medicine composition of the proliferation of mammary gland and preparation method thereof | |
CN106177007B (en) | It is a kind of to be used to treat Chinese medicine suppository of cervical disease of high-risk HPV persistent infection and preparation method thereof | |
CN104000938B (en) | Traditional Chinese medicine composition for treating IgA nephropathy and application thereof | |
CN103721109B (en) | A kind of medicament for the treatment of chronic cholecystitis | |
CN106109930A (en) | A kind of Chinese medicine preparation treating lumbago and skelalgia and preparation method | |
CN109248269A (en) | A kind of traditional Chinese medicine for outer use for treating hyperplasia of mammary glands | |
CN114732887B (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
CN102813815A (en) | Traditional Chinese medicine composition for treating chronic pyelitis | |
CN102908566B (en) | Medicament for treating interstitial pneumonia | |
CN102441138A (en) | Traditional Chinese medicinal inflammation-removing decoction for treating acute mastitis | |
CN103948716A (en) | Medicine for treating wind-heat cold and tablets | |
CN104740543A (en) | Drug for treating flat warts and preparation method for drug | |
CN106138881A (en) | A kind of Chinese medicine composition for treating pelvic inflammatory disease | |
CN104523852A (en) | Anti-cold traditional Chinese medicine composition and application thereof | |
Zhao et al. | Study on the treatment of complication of sepsis by traditional Chinese and Western Medicine | |
CN104906441A (en) | Traditional Chinese medicine for treating damp-heat pouring downward syndrome non-gonococcal urethritis | |
Zhu et al. | Research of COVID-19 epidemic Model based on SEIR Model | |
CN104524249B (en) | A kind of Chinese medicinal capsule for treating urinary tract infections | |
CN103908501B (en) | A kind of Chinese medicine composition for the treatment of pityriasis rosea | |
CN103768341A (en) | Traditional Chinese medicine effective part composition for treating primary glaucoma | |
CN103877342A (en) | Medicament for treating plasma cell mastitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170511 Address after: 226100, No. 588, Jinyang Road, Yue Yue town, Haimen, Jiangsu, Nantong Patentee after: Haimen Yue Yue Textile Co., Ltd. Address before: 276400 Linyi health center, Yishui, Shandong, China, Yishui Central Hospital, No. 17, Patentee before: Dong Yun |